Reaktion #64548

ord-f30de52a8a794d1fa33ee1a40884c2d8

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Einengenconcentrated to dryness
  2. 2
    workup.DISSOLUTIONThe residue was dissolved in 1 mL of methanol
  3. 3
    workup.ADDITIONacidified to approximately pH 1.5 by addition of 1N HCl (methanolic)
  4. 4
    Einengenagain concentrated
  5. 5
    workup.DISSOLUTIONThe residue was dissolved in CHCl3
  6. 6
    Trocknendried over Na2SO4
  7. 7
    Filtrationfiltered through Celite
  8. 8
    SonstigeEvaporation of the solvent

Vorschrift

A solution of 71 mg (0.102 mmole) of 5-n-butyl-2-[5-(carbomethoxy)-2-chlorophenyl]-4-[[2'-[N-(2-chlorobenzoyl)-sulfamoyl]-biphenyl-4-yl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one (from Example 65, Step D) in 0.7 mL (0.7 mmole) of 1N NaOH (methanolic) was stirred at 60° C. overnight and then concentrated to dryness. The residue was dissolved in 1 mL of methanol, acidified to approximately pH 1.5 by addition of 1N HCl (methanolic), and again concentrated. The residue was dissolved in CHCl3, dried over Na2SO4, and filtered through Celite. Evaporation of the solvent yielded 58 mg (84%) of the title compound as a white solid; nearly homogeneous by TLC in 9:1 CH2Cl2 --MeOH; mass spectrum (FAB) m/e 679 (M+1)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05411980uspto-grants-1995_05